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The aim of this study was to assess the cancer nursing research papers published in
the past decade; identify their characteristics in terms of country of origin,
participants, settings, diagnostic foci, and methodologic choices; and evaluate
their quality. A systematic review was carried out of all published papers in the
Cumulative Index of Nursing and Allied Health Literature between the years 1994
and 2003, using the keywords ‘‘cancer,’’ ‘‘nursing,’’ and ‘‘research.’’ A total of 619
papers met inclusion criteria and were evaluated by 5 researchers. Almost half the
papers were derived from the United States (49.1%), followed by the UK, Sweden,
Canada, and Australia. In more than half of the published papers (52.2%), health
professionals (mostly nurses) were the studies’ participants. Also, much of the
published research used patients with mixed diagnosis, or patients with breast or
hematologic cancers. Two-thirds of the studies were quantitative, whereas most
studies were descriptive in nature. The quality of both quantitative and qualitative
studies was low, with only a small percentage meeting the highest quality criteria.
Studies reporting funding and those published in journals with an impact factor
showed a higher quality score than those not reporting funding or not published in
journals with an impact factor. Cancer nursing research is still in a developmental
stage, although it has made a considerable contribution to the evidence base of the
discipline. A number of issues need to be tackled before we improve our output, such
as organizational or workforce issues, infrastructure support, funding, and
methodologic challenges.
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N
ursing research in general is a rapidly developing
field, although its performance against other bio-
medical disciplines is considered to be poor. This is
especially evident in the countries where national research
assessment exercises take place, such as in the UK, Australia,
Hong Kong, New Zealand, South Africa, and elsewhere.
Reasons for this poor performance are discussed and debated
widely, and include among other reasons the lack of a
research culture in nursing and chronic underfunding.1Y3
Nevertheless, these data are limited to countries where such
an assessment exercise takes place, and they do not necessarily
reflect the situation in the United States or Canada.
Undoubtedly, cancer nursing has established itself as a
main nursing specialty and the discipline looks to research to
provide the evidence base for its practice. Since 1974 when
the first dedicated journal for cancer nursing research was
established (Oncology Nursing Forum), followed in 1978 by
the first international peer-reviewed cancer nursing journal
(Cancer Nursing), many nurses have carried out research and
disseminated research findings. Since then, research has
rapidly expanded and a number of other cancer nursing
journals were founded, including (indicatively) a specialist
pediatric oncology nursing journal in 1984 ( Journal of
Pediatric Oncology Nursing) and followed in the 1990s by
European journals, such as the European Journal of Cancer
Care in 1994 and the European Journal of Oncology Nursing in
1997, all publishing international research. Such expansion
in academic peer-reviewed journals highlights the acute need
for disseminating through such mediums, ever increasing
cancer nursing research activity. It also illustrates the relative
‘‘youth’’ of the academic discipline of cancer nursing research.
Furthermore, this also reflects what Wilson-Barnett4 calls a
‘‘new level of maturity’’ in some areas of cancer nursing
research that reflected the researchers’ determination to tackle
challenging practice issues and to offer cogent presentations
of sophisticated research studies. However, no formal evalua-
tion has taken place so far of the cancer nursing research
output and its characteristics. Indeed, no such evaluation was
found for any other nursing specialty. Such evaluation is
important for identifying trends, uncovering gaps, and
providing new research directions, and cancer nurses may
use such findings as a guide in developing their future
research endeavors.
There are a number of ways to evaluate the quality of
published research, including citation analysis or bibliometric
measurement. However, as a discipline, nursing is not well
represented in the Institute for Scientific Information (ISI),
which produces the annual journal citation reports and
includes only 1 cancer nursingYspecific journal among the
36 included in the ISI for 2004 (Cancer Nursing). A second
journal included in the ISI edited by a nurse, publishing a
considerable number of nursing papers (European Journal of
Cancer Care), is considered to be multidisciplinary in nature
and it is not listed in the nursing index of the ISI. Hence, an
evaluation was carried out by reviewing papers cited in
Cumulative Index of Nursing and Allied Health Literature
(CINAHL), an electronic database of publications which
includes mostly nursing/allied health journals. The aim of
this evaluation was to quantify cancer nursing research output
and identify key trends and issues that have proven relevant to
cancer nurse researchers. Specific objectives were:
a. to describe the publication output of cancer nursing
research in terms of country of origin, areas of foci,
subjects, settings, and methodologies used,
b. to explore whether published work is funded or not, and
c. to assess the quality of both quantitative and qualitative
studies published.
n Methods
A review of the literature was carried out between the years
1994 and 2003, covering a decade of research. It is acknowl-
edged that cancer nurses publish in journals of other
disciplines (ie, medical or psychologic), but it would have
been difficult to identify which papers were specifically
written by nurses. Keywords used for retrieval of publications
included ‘‘cancer’’ (MeSH term: neoplasm), ‘‘nursing,’’ and
‘‘research.’’ ‘‘Nursing’’ is an MeSH term used with diseases
for nursing care and techniques in their management. It
includes the nursing role in diagnostic, therapeutic, and
preventive procedures. Papers were included in the review if
they were reporting research findings of any language and
were published between January 1, 1994 and December 31,
2003 in CINAHL. Papers were excluded if they were
literature reviews, clinical reports, dissertations, conference
abstracts, other gray literature, discussion papers, editorials,
or letters to the editor, in order to capture only the output of
published research.
n Data Collection
A data extraction sheet was developed to obtain the required
data from each paper. Items included the year of publication,
the country of origin of the article, title of paper and first
author, the name of the journal where it was published, the
impact factor of the journal (if any), the language of the
paper, the setting of the study, the population (adult cancer
or children and young people), description of participants,
the background of the principal investigator (both in terms
of profession and place of work), diagnostic group of pa-
tients participating in the study, funding source (dichoto-
mous yes-no item), methods used (both in terms of design
and data collection method), and sample size. A keyword
describing the focus of the study was also included. Finally, 2
sections made judgments about the quality of the reports, one
devoted specifically to quantitative and the other to quali-
tative studies. Country of origin was considered to be that
reported under the principal investigator’s name, although on
several occasions consultation with other bibliographic
sources was necessary to confirm this.
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n Assessment of the Quality of Studies
The quality of quantitative studies was assessed using a 3-
grade system developed by Mann5 and adapted by the NHS
Centre for Reviews and Dissemination at the University of
York in the UK, as part of specific improving outcomes
series. In more detail, grade I refers to randomized controlled
trials, subdivided into grade IA, where sample size has been
calculated and an accurate, standard definition of outcome
variables is provided; grade IB, where only the latter is
provided; and grade IC, where neither of the 2 are provided.
Grade II refers to prospective studies with a comparison
group (nonrandomized trial or good observational study) or
retrospective studies with controls effectively for confounding
variables. This grade is subdivided into grade IIA, where
calculation of sample size has taken place, accurate standard
definition of outcome variables is provided, and adjustment
for the effects of important variables is included; and grade
IIB where at least one of the above is provided. Finally, grade
III includes all other studies, subdivided into IIIA, when a
comparison group, calculation of sample size, and accurate
standard definition of outcome variables are included; grade
IIIB, when at least one of the above is included; and grade
IIIC when none of these are included.
Qualitative studies were assessed using a rating system de-
veloped by Cesario et al.6 Accordingly, studies were scored in
relation to 10 items on a scale of 0 = no evidence, 1 = poor, 2 =
fair, and 3 = good evidence. Items inquired about the descrip-
tive vividness of the study, methodologic congruence (rigor
in documentation, procedural rigor, ethical rigor, and con-
firmability), analytical preciseness, theoretical connectedness,
heuristic relevance (intuitive recognition and relationship to
existing body of knowledge), and applicability. Scores between
22.5 and 30 represented studies of good quality (QI), scores of
15 to 22.4 represented studies of fair quality (QII), and scores
less than 15 reflected studies of poor quality (QIII).6
n Process
All the abstracts from the articles identified through the data-
base were retrieved. One reviewer read all abstracts and
excluded those that did not meet the inclusion criteria. Then,
the full text of the selected papers was obtained, either
electronically or by ordering articles. A pilot assessment of
both the core and qualitative and quantitative data extraction
sheet was carried out with 10 papers. Subsequently, several
items on the sheet were expanded or clarified. A review team of
5 researchers undertook the data extraction. The reviewers
were all experienced in conducting systematic reviews with 3 of
them having published such reviews in the past in prestigious
journals and all having contributed in the past in such reviews.
All reviewers were educated at the PhD level. All 5 reviewers
took part in reviewing the papers and completing the data
extraction sheet. The number of papers they reviewed ranged
from 70 to 300 each, based on the reviewers’ specialty and
experience with the wider topics (ie, all papers referring to
children and young adults were reviewed by an experienced
children’s and young adult’s researcher/lecturer). Each paper
was reviewed by one of the team members and then one other
reviewer (A. M.) checked all data extraction sheets for con-
sistency with the terms used and to identify and resolve where
possible any missing data. The same reviewer also assessed a
random sample of about 20% of all papers to assess whether
the 2 reviewers agreed in these cases, thus exploring interrater
agreement. Agreement with the review data was high, with
disagreements present in only about 30 papers altogether,
mostly in relation to the keyword used for the therapeutic focus
of the paper, which was resolved after discussion.
Keywords describing the focus of each study (nearly 200)
were grouped together under a smaller number of broad cate-
gories, using simple thematic analysis. Three of the 5 reviewers
took part in the classification of keywords: all keywords were
grouped by one of the reviewers and then categories and
keywords were checked independently by 2 reviewers. Final
categories were agreed completely by all 3 assessors.
n Data Analysis
Data were coded and entered into a statistical package (SPSS).
Descriptive statistics were used with all variables, summarizing
the data. Kruskal-Wallis tests were carried out between the
quality of the published papers and whether an impact factor
was assigned in a journal or not, and between the quality of the
published papers and whether the study was funded or not. For
each country, the number of publications was calculated. The
ratio of publications per country was also calculated in terms of
each country’s population (expressed in millions of inhabitants)
and gross domestic product (expressed in billions of $US). The
latter comparator was used as an indicator of productivity often
used in other similar medical studies10 and also because the
cancer nurses’ population in most of the countries around the
globe is not known or recorded (indeed, cancer nursing as a
specialty is not recognized in many countries). It was not
possible to calculate other variables, such as the relationships
between graduate-level education in cancer nursing and research
activity for different countries, as often such information was
not reported in the papers.
n Results
A total of 751 papers were obtained from the database, but
132 were excluded following review of the abstract because
they failed to meet the inclusion criteria. A total of 619 papers
were retrieved and included in the analysis (list available upon
request). There was a mean of 62 papers published per year
with a fairly similar number of publications published each
year over the chosen decade (Figure 1). For comparison, there
were 3,230 publications in CINAHL under the keyword
‘‘oncologic nursing’’; 689 publications in PubMed database
using the keyword ‘‘cancer nursing’’ and ‘‘research’’; and
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12,406 papers published in CINAHL over the same period
under the keyword ‘‘nursing research.’’
Almost half of the papers came from the United States
(49.1%), followed by the UK (18.4%) and Sweden (8.2%)
(Table 1). The European Union countries combined (includ-
ing Norway which is economically linked to European Union)
accounted for 34.1% of the total number of published papers
(n = 211 papers). China includes Hong Kong and Taiwan,
although the majority of the papers were actually derived from
Hong Kong. However, if the number of publications is
divided by the country’s population (rounded to 2 decimal
points), the highest output is derived from Sweden (5.6
papers/million of inhabitants), followed by Finland (2.8/
million), UK (1.9/million), Norway (1.55/million), and
Canada (1.48/million). Compared with gross domestic
product, the countries with the highest output included
Sweden, Finland, the UK, Canada, and Australia (Table 1).
Only 41% of the papers were published in journals with
an impact factor, whereas the other 59% were not published
in such journals. Impact factors were generally low, with a
mean impact factor of 0.99 (range = 0.18Y2). One-fifth of
the papers came from Cancer Nursing (21.5%) and another
fifth from Oncology Nursing Forum (20.7%). Papers were
published in 77 different journals but 13 journals provided
82.5% of the data, whereas all other journals contributed
with less than 1% of the data each (Box 1).
Box 1. Journals where more than 1% of cancer
nursing research publications appeared for the
current review (in descending order).
Cancer Nursing
Oncology Nursing Forum
Journal of Pediatric Oncology Nursing
Journal of Advanced Nursing
European Journal of Oncology Nursing (1997Y2003)
Canadian Oncology Nursing Journal
International Journal of Palliative Nursing (1995Y2003)
European Journal of Cancer Care
Journal of Clinical Nursing
Clinical Effectiveness in Nursing (1997Y2003)
Journal of Cancer Education
International Journal of Nursing Studies
International Journal of Nursing Practice (1995Y2003)
(NB. The complete list includes a total of 77 journals)
The language of the papers was primarily English
(97.6%), with a small number of papers published in
Portuguese (n = 2), Spanish (n = 3), Africaans (n = 2),
German (n = 2), Finish (n = 1), and Chinese (n = 1).
Funding was reported in 48.4% of the papers, while the
rest (51.6%) did not report funding sources.
Table 2 shows the setting of studies, primarily a hospital/
cancer center (71.1%), with studies carried out in the
inpatient setting being more than double those in outpatient
setting (n = 288 vs 134). The study population included adult
Table 1 & Cancer Nursing Research Papers
Published in Journals Listed by
CINAHL Between 1994 and 2003
by Country (n = 619)
Country
No. of
Papers
(%)
Ratio of
Papers by
Country’s
Population
Ratio of
Papers by
Country’s Gross
Domestic
Product
United States 304 (49.1) 1.05 0.03
UK 114 (18.4) 1.9 0.07
Sweden 51 (8.2) 5.6 0.2
Canada 46 (7.4) 1.48 0.06
Australia 24 (3.9) 1.2 0.06
Finland 14 (2.3) 2.8 0.1
Netherlands 11 (1.8) 0.69 0.02
China 10 (1.6) 0.007 0.008
Norway 7 (1.1) 1.55 0.03
Greece 6 (1) 0.54 0.04
Japan 5 (0.8) 0.04 0.001
Denmark 4 (0.6) 0.8 0.02
Israel 4 (0.6) 0.66 0.04
Belgium 3 (0.5) 0.03 0.01
Spain 3 (0.5) 0.07 0.004
South Africa 3 (0.5) 0.06 0.03
Italy 2 (0.3) 0.03 0.001
Portugal 2 (0.3) 0.2 0.01
Brazil 2 (0.3) 0.005 0.004
Iran 1 (0.2) 0.01 0.009
Germany 1 (0.2) 0.01 0.0005
Egypt 1 (0.2) 0.01 0.01
Korea 1 (0.2) 0.02 0.002
CINAHL indicates cumulative Index of Nursing and Allied Health Literature.
Figure 1n Cancer nursing research papers
published between 1994 and 2003 in
journals listed by CINAHL.
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cancer patients (49.8%), nurses (31.5%), children and young
people (15.9%), both adults and children (2.3%), and other
health professionals (0.5%). More specifically, participants
were mainly nurses and patients with early disease or
advanced disease (Table 3).
Most of the authors (referring to Principal Investigator
[PI]) were most often affiliated with an academic institution/
university (63.1%), 36.3% of PIs were clinical nurses, 0.4%
came from charities, and 0.2% from the industry. In most
cases, the PI was a nurse (93%). Furthermore, most studies
were single-site studies (63.7%), with 36.3% being multi-
center (with at least 2 centers involved). Similarly, the
research team composition (authorship) was usually from a
single institution (60.6%), with 39.4% from more than 1
institution. Evidence of multidisciplinary research team com
position existed in only an almost negligible fraction of the
published papers.
In terms of diagnostic focus, most studies used mixed
cancer samples (n = 289, 63.6%), followed by studies using
patients with breast cancer (14.6%) and patients with
hematologic cancers (10.5%) (Figure 2). Nearly one-third
(2.8%) of the hematologic papers were specifically related to
patients who had undergone a bone marrow transplant. As
can be seen in the same figure, the diagnostic focus of cancer
nursing research did not match the incidence percentage (for
1998) of these cancers.
Two-thirds of the published studies were quantitative in
nature (60.2%), whereas 31.3% were qualitative and 8.5%
used mixed methods. As can be seen in Table 4, most
quantitative work was descriptive and used survey designs,
whereas the most common qualitative design was phenom-
enology. The most common data collection method (56.2%)
was a questionnaire (Table 5). Sample sizes ranged from 1
subject to 2,855. The mean sample size for quantitative work
was 204, whereas the mean sample size for qualitative work
was 26 (while the mode for the latter was 10). Two hundred
seventy-five (46.5%) of the studies involved samples of less
than 50 subjects (11.5% with less than 10 subjects), with 113
studies (20%) between 51 and 100 subjects, 144 studies
(26.5%) between 101 and 500 subjects, 21 studies (4%)
between 501 and 1,000 subjects, and 15 studies (3%) had
over 1,000 subjects.
As can be seen in Table 6, most quantitative studies were
considered to be grade III, suggesting low quality. There was
a significant difference between the quality score assigned and
whether the paper was published in a journal with an impact
factor or not (P G .001), with those published in a journal
with an impact factor demonstrating a better quality scoring
overall. Similarly, studies which reported a funding source
had a significantly better quality scoring than those not
reporting a funding source (P = .002). Quality assessments of
the qualitative studies were also low, with most papers scoring
in the category of ‘‘poor’’ (Table 6). Once again, papers
published in journals with an impact factor had a significantly
better quality score (P = .003). There was also a trend in
qualitative studies that reported a funding source to score
better in terms of quality (P = .071), but this did not reach
statistical significance.
Simple thematic analysis, as described earlier for the
keywords, was also used to categorize the words used to
describe the foci of research. The 5 most common categories
of study focus were related to symptoms; nursing issues/roles;
psychosocial issues; cancer services; and experiences of
patients, caregivers, and nurses (Table 7). The category of
‘‘symptoms’’ included mostly descriptive studies of various
symptoms as well as symptom assessment and symptom
management studies. Pain and fatigue were the symptoms
with the largest number of papers (26 and 17, respectively),
whereas other symptoms, represented only with a small
number of papers, included infections (n = 2), nausea and
vomiting (n = 2), sleep (n = 3), skin and wound care (n = 4),
diarrhea (n = 2), breathlessness (n = 2), mouth care (n = 4),
and lymphedema (n = 1). The category of psychosocial issues
had ‘‘coping’’ as its most common topic. The category of
complementary therapies included studies on relaxation,
massage, music therapy, art therapy, and therapeutic touch.
Nursing concepts included comfort, caring, humor, hope, or
grief. The category of ‘‘research issues’’ primarily included
Table 3 & Participants in the Studies Included in
the Review*
n %
Nurses 284 46.9
Early disease 166 27.4
Advanced disease 128 21.2
Carers/relatives/parents 64 10.6
Children 48 8.0
Other health professionals 27 4.5
Healthy subjects (at risk for cancer) 6 1.0
Student nurses 5 0.8
Other 7 1.2
Not specified 18 3.0
*Percentages are higher than 100%, as in some studies there was more than 1
group of participants included. Thirty-one (5.1%) studies did not include
any participants but were record reviews, reviews of published papers, or
documentary analysis.
Table 2 & Settings, Location, or Source of
Information Regarding the Studies
Included in the Review*
Setting/Sources of Information n %
Hospital/cancer center 322 71.1
Community 121 20.4
National (surveys) 58 9.7
International (surveys) 19 3.2
Hospice 10 1.7
Records/papers 10 1.7
Educational 7 1.2
Other 45 6.0
*Percentages are higher than 100%, as in some studies there were more than
1 setting or source of information reported.
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studies on research priorities (12/21). Other studies with
small frequencies that were not classified in the above
categories included studies on sexuality, culture, meaning of
illness, central venous access devices, smoking cessation, and
primary care issues.
n Discussion &
The current study is the first systematic assessment of
cancer nursing research to date. It showed that over a period
of 10 years, 619 cancer nursing research papers were
published worldwide. Although this number may not seem
overly impressive, it does show a significant contribution to
the body of nursing knowledge. However, in the absence of
other nursing specialty comparators, it is difficult to draw
definitive conclusions. The only comparator available is from
the broad area of ‘‘supportive and palliative care,’’ where
worldwide output from all disciplines and all journals from
Table 5 & Data Collection Methods Used in the
Reviewed Studies*
Data Collection Method n %
Questionnaires 335 56.4
Interviews 187 31.5
Observation 55 9.3
Physiologic measures 30 4.6
Focus groups 27 4.6
Chart/record review 36 6.1
Literature search 12 2
Narratives-story telling 3 0.5
Video-recording 3 0.5
Other 4 0.7
*Percentages are higher than 100%, as in some studies there was more than 1
data collection method used (mixed designs).
Table 4 & Designs Used in the Studies Reviewed
Design n %
Descriptive studies 244 40.4
Cross-sectional/survey 180 29.5
Prospective/longitudinal 49 8.1
Retrospective 17 2.8
Comparative/quasi-experimental 47 7.7
Phenomenology 46 7.4
Randomized trial 36 5.9
Pilot study 25 4.1
Grounded theory 15 2.5
Record review 15 2.5
Delphi technique 14 2.3
Ethnography 12 2
Instrument validation 12 2
Systematic review 12 2
Secondary analysis of data 11 1.8
Audit 11 1.8
Case study 8 1.3
Action research 7 1.2
Ethology 4 0.7
Concept analysis 2 0.3
Meta-analysis 2 0.3
Educational evaluation 2 0.3
Qualitative testing of intervention 1 0.2
Psychoanalytic approach to interview 1 0.2
Crossover 1 0.2
Other, unclassified or missing data 91 12.8
Figure 2n Percentage of papers published with a specific diagnostic focus compared with the incidence of cancers in the developed
world.* *Cancer incidence is based on data from References 7 and 8.
436 n Cancer NursingTM, Vol. 29, No. 6, 2006 Molassiotis et al
Copyr ight ' Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Copyr ight ' Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
both the Science Citation Index and the Social Science
Citation Index between 1994 and 2002 was an average of 977
papers annually.9
There does not seem to be a significantly increased output
over the years, although it is evident that after 1998 more
papers were published, perhaps as a result of the establish-
ment of 2 more cancer nursing journals around this time.
Also, the role of the Internet is likely to increase the available
sites for nurses to share research findings in the future and
this may have an effect in studies published in traditional
academic nursing journals.
The United States was by far the country contributing
most papers with almost half the papers included in the
review coming from this nation. This is not surprising as the
United States has a longer history of nursing research, started
university-based nursing training ahead of many other
countries, has more access to research funding (ie, NCI) than
any other country, and has been professionally organized with
a very strong and influential Oncology Nursing Society for
some time. However, when these results are seen in light of
each country’s population, the Nordic countries (Sweden,
Finland, and Norway) seem to be leading the way together
with the UK. Sweden by far exceeds publication rates, with
5.9 publications/millions of inhabitants, with the United
States being only seventh in this order. What is interesting is
when publications are compared with each country’s popu-
lation, small countries, such as Denmark, the Netherlands,
Israel, Greece, and Portugal, are all included in the top 12
countries of publication. Similar results are also obtained for
publications in relation to each country’s gross domestic
product, with Finland and Sweden leading the way again, and
with the United States being only 13th in this order behind
small countries such as Portugal, Norway, Denmark, Israel,
and Greece. Similar trends are also observed in biomedical
cancer research,10 whereby it was shown that smaller
countries such as Greece doubled their output in the past
decade and Belgium substantially increased output, whereas
significant increases in the mean impact factor of published
papers were noted for countries such as the Netherlands,
Finland, Austria, Greece, Belgium, and Spain. The higher
publication rates from Sweden and Finland may be influ-
enced by the fact that PhD students must publish a number
of papers before they can defend their theses as well as the
considerable funding available from the Nordic Cancer
Societies. It is notable that smaller countries, such as Nordic
countries, Greece, Netherlands, Israel, and Portugal, contrib-
ute with a significant output related to cancer nursing
research. Clearly, there are professional, cultural, and histori-
cal factors that merit further research to explain this finding.
Nevertheless, although the United States is undoubtedly in
the leading position of cancer nursing research publications,
the publication number is not a poor showing on behalf
of the other countries, if the difference in the availability of
research funding in the United States and Europe or rest of
the world is considered.
For those papers published in journals with an impact
factor, the mean impact factor was 0.99. This is encouraging,
compared with all ‘‘nursing’’ journals listed by the Social
Sciences Citation Index for 2004, whereby the highest journal
has an impact factor of 1.71 and only 6 journals achieved an
impact factor of more than 1.00. This suggests that cancer
nursing research is being published in nursing and nonnursing
journals (with higher impact factors), thus influencing both
cancer nursing and the wider cancer care arena. Many cancer
Table 6 & Quality of the Reviewed Studies
N %
A. Quantitative studies
IA 2 0.5
IB 15 3.5
IC 22 5.1
IIA 7 1.7
IIB 43 10
IIIA 7 1.7
IIIB 98 22.8
IIIC 226 54.7
B. Qualitative studies
QI (Good) 13 6.5
QII (Fair) 62 32
QIII (Poor) 123 61.5
Table 7 & Foci of Studies Reviewed
No. of occurrences
Symptoms 108
Nursing issues/roles 87
Psychosocial issues 57
Cancer services 48
Experiences of patients, carers, and nurses 33
Quality of life 23
Nursing theory and concepts 22
Research issues: utilization, barriers, priorities 21
Patient education 17
Complementary therapies 17
End-of-life issues 16
Communication 13
Patient-nurse relations 12
Cancer treatment effects 11
Spirituality 11
Ethical issues 11
Needs assessment 11
Decision making 10
Burnout and job satisfaction 9
Nursing diagnosis 7
Patient information needs 7
Patient satisfaction 6
Patient follow-up 6
Prevention 6
Occupational safety 5
Nursing education 5
Administration of chemotherapy 4
Development of scales 4
Other 32
Total 619
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nursing researchers admittedly publish their work in biomed-
ical and psychosocial journals with higher impact factors not
listed by CINAHL; however, these would have been difficult
to identify for the pragmatic reasons explained earlier.
Furthermore, although papers were published in an extensive
list of 77 journals altogether, most papers (82.5%) were being
published in a small number of high-quality and reputed
journals, half of which have an impact factor. This also
suggests a growing sense of academic community within cancer
nursing and an emergence of highly respected journals with
robust peer review systems.
The language of publication in most of the papers was
English, suggesting a publication bias toward English-speaking
countries (or where English is a major language), but also a
bias in the electronic databases, such as CINAHL, which
include only a small number of journals not published in En-
glish. From experience, many researchers from non–English-
speaking countries find it difficult to write in English at an
academic level. The near-monopoly of English as the medium
of communicating research is a major obstacle in sharing
practice and research worldwide. This may professionally isolate
nurses who cannot have access to readily available evidence for
their practice in their own language. Once again, the contribu-
tion of the Internet may alter this situation in the future.
Half the papers had nurses or other health professionals as
participants. This, in combination with one of the most
common research foci being ‘‘nursing issues/nursing roles,’’
suggests that a large part of the research carried out is
concerned with professional and practice development issues
as well as role delineation. This may suggest that nurses have
concerns with their own role and the needs of patients at
particularly difficult times during their illness. This may also
be indicative of the developmental stage of cancer nursing,
indeed a characteristic of nursing as a whole. Nevertheless,
there was a decrease over the years about ‘‘nursing issues’’
because although they accounted for 43% of the papers
published in 1994, they accounted for 14% to 30% of the
papers published over the following decade. Much of the
patient-oriented work is with patients earlier in their disease
trajectory, perhaps because work with patients with advanced
cancer can be perceived as more challenging for both practical
and ethical reasons. Work with caregivers is minimal, with
only 1 out of 10 studies focusing on caregivers. This is often a
group with unmet needs and an underresearched group,
hence, future work should address the needs of carers.
Much of the published work are derived from academic
settings using a single site only for data collection. This is an
expected finding as universities strive for excellence in a
competitive academic market. Publication profiles are a key
means for increasing their prestige and can act as a quality
indicator for nurses employed there. However, as joint posts
between academic and clinical institutions emerge, this
situation may also change in the future.
The very small proportion of multidisciplinary work is
disappointing, especially in the current context of global
complex problems requiring an interdisciplinary approach. It
has frequently been argued that nurses should participate in
interdisciplinary research.11 If many of the most difficult
problems in global or local healthcare are to be solved, they
must be tackled from a broader context than any single
discipline can provide. Involving researchers from a range of
disciplines enables research teams to consider issues from a
wide variety of perspectives using a range of methodologic
approaches if we are to achieve positive outcomes. This also
increases professional isolationism and misses out the
opportunity to influence care at a broader healthcare level.
We also need to be confident in our own unique contribution
to researching the issues and concerns that cancer patients
face and build on our unique strength, that of our focus on
the human experience and commitment to making the
experience as good as it can become.12
The diagnostic focus of research seems disproportionate to
the disease burden. With 6 out of 10 studies focusing on
generic issues of patients with a mixed cancer diagnosis, it
suggests that research seems to concentrate on broad issues
across all cancers rather than on specialist care needs. With
the exception of breast and hematologic cancers (where most
of the specialist cancer nursing research is), all other research
has been limited in specific diagnostic foci and is dispropor-
tionate to specific disease burden. There is an urgent need to
move from generic issues that have already been researched to
an exploration of more complex and specialist research, which
is proportionate to the disease burden. There is absence of
work with a number of cancers (ie, brain, testicular, stomach,
liver, pancreatic, or bladder) and minimal work with some of
the most common cancers (ie, lung, colorectal, or prostate).
This is a similar finding within biomedical publications and
often relates to the funding awarded from large funding
agencies.7 This diagnostic focus is also absent from research
with children and young people, where, other than brain
tumors, research often seeks to include the range of
hematologic and solid tumors.
Two out of 3 studies were quantitative, using mostly
descriptive and survey designs. Time constraints of clinical
nurses, lack of funding for most of the cancer nursing
research, and the fact that much of the unfunded work are
derived from nurses carrying out small-scale research as part
of a postgraduate degree may all contribute to this picture. It
is also evident that more complicated research designs
account for a very small proportion of the overall research
output. Among the qualitative research designs, phenome-
nology seems to be the most preferred design, which may
suggest an interest in the experience of cancer from the
perspective of the nursing profession.
The quality of the studies reviewed could be considered
disappointing. Very few studies, both quantitative and
qualitative ones, received high scores. In the majority,
important information was not reported, sample sizes were
not calculated beforehand, the power of the study was not re-
ported, control for confounding variables was minimal, and
clear definitions of outcome variable was absent. Much of the
qualitative studies attempted to explain the (often complex)
theoretical underpinnings of the chosen method in one small
paragraph (which was all the ‘‘Methods’’ section of the
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article). Inaccuracies and inconsistencies in the study design
and explanations were often noticed. Lack of detail was the
key characteristic of most of the studies. Previous commenta-
tors have drawn attention to the need to improve the quality
of qualitative research evidence, in particular, attention needs
to be given to methodologic and philosophical detail.13 If
cancer nursing research is to be taken seriously by our
interdisciplinary colleagues, quality of reporting should be the
first and most important step toward this direction. Further,
limited detail makes it almost impossible to allow for the
replication of studies. Sample sizes were, however, generally
appropriate for the particular designs used.
Symptoms were the most common focus of the studies.
This work was mostly descriptive, with little work into
symptom management. Work predominantly concentrated
on pain and fatigue, accounting for almost 4 out of 10
papers, whereas all other symptoms received minimal
attention. Given the complex nature of the symptoms
involved, the emphasis on pain and fatigue is not surprising.
Nursing issues/roles and cancer services were also common
foci of research, suggesting that work around role and practice
development, together with research around experiences,
psychosocial, and quality of life issues, highlights substantial
amounts of research that continue to focus on researchers’
particular interests rather than on national or international
research priorities.14
Research concerning research priorities was a common
theme from many parts of the world, however, findings
appear to have little relationship with published research
priorities. A lot of the research that takes place is dictated by
funding priorities, availability of funds, time, resources, and
access to specific populations, all of which are outside the
sphere of nursing influence or control. Hence, it seems that
researching and disseminating research priorities for cancer
nursing have not influenced the specialty’s research directions
in a concrete way. For example, although symptom manage-
ment is a research priority identified by American,15
Canadian,16 European,17 and Australian18 studies, the cur-
rent review showed that most of the work around symptoms
is descriptive in nature, with little research around managing
symptoms through publishing trials or interventions. Pain,
quality of life, and patient education identified as a research
priority in past American and European studies15,17,19
seemed well researched in this review, although other key
priorities identified in the past, such as issues around decision
making, screening and prevention, ethical issues or commu-
nication, were not well-researched areas during the past 10
years. Furthermore, over the 10 years assessed, the issues
examined were relatively stable, with only studies focusing on
‘‘nursing issues’’ decreasing, with an increasing focus on
‘‘patient issues.’’ There also was a trend in qualitative work
increasing (but not substantially) over the years.
The keywords used for this study may be a limitation, as it
may have excluded a number of other studies that may have
been nurse-led but did not appear in the literature search
under the keyword ‘‘nursing.’’ A broader search strategy may
have resulted in the identification of other papers, although
filtering these as nursing or nonnursing would have been
difficult. Indeed, a number of the papers published by the
authors of the current work did not come up in the list of
papers examined, as the keyword ‘‘nursing’’ was not included
in their index of keywords. However, we were interested in
broad patterns of cancer nursing research rather than more
specific issues. Nevertheless, the article still provides a fair
representation of the research cancer nurses are doing world-
wide, as it covers all publications in cancer nursing journals.
n Conclusions and Recommendations
for Future Research &
As some areas of cancer nursing research reach a stage of
maturity, there is an urgent need for more influential and
innovative work. We need to engage in broad-spectrum
research of patient problems and how to manage theseVfor
example, what is the complementary orientation and unique
contribution of cancer nursing research, what are the most
effective methods of providing supportive care and at differ-
ent points in the cancer continuum. The focus should be on
methodologic challenges, research considerations, and gaps in
the evidence base of our profession establishing who we are,
what we do, and what effect we have on patient outcomes, as
detailed by Richardson et al.14 The drive toward evidence-
based practice is essential for cancer nurses to establish who
they are, what they do, and what effect they have on patient
outcomes. A recent document by the UK’s National Cancer
Research Institute highlights, after reviewing nearly 9,000
papers in supportive and palliative care, that: (a) work needs
to focus more on symptoms such as breathlessness, fatigue,
cachexia, agitation, or depression; (b) work needs to develop
on effective solutions to meet patients needs; (c) evaluate
services; (d ) increase work with elderly people and different
cultural groups; (e) focus on information delivery for patients,
and (f ) develop intervention studies carried out by multi-
disciplinary research teams.9
Symptom management and complex interventions should
be a priority for future research, given the popularity of
‘‘symptoms’’ so far, with a more balanced focus toward
symptoms other than pain and fatigue. More studies are
needed with specific and common cancers (other than breast
and hematologic). We need to gain more access to funding and
publishing such research, and concentrating in a small number
of influential and high-quality journals for dissemination of
such findings. We also need to work together and collaborate
with other disciplines developing multidisciplinary themes (eg,
nutrition or psychosocial care) and exert influence through our
publication output not only to cancer nursing but to the wider
cancer care community (although to some extent, especially
from senior researchers, this is already happening).
A number of issues need to be considered that may drive
up the quality of cancer nursing research. There is a need to
focus on infrastructure to support our research9,12 as our lack
of progress is intimately related to our research environment.
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There is a need to develop a structure to support programs of
research. There are very few senior cancer nursing researchers
developing programmatic research, and this needs to be
improved; from our own experience, there are only a handful
of researchers who hold program grants in the United States,
several in Canada with a focus however on end-of-life care,
and only 2 [collaborative] program grants in the UK.
However, several senior researchers have built programs
of research, and Oncology Nursing Forum is publishing
annually in issue 5 a distinguished nurse researchers program
of research (ie, the program of research on fatigue by Mock20
or Frank-Stromborg’s work in the rural settings21 and others).
The NCRI9 (used here as it is the only comprehensive report
available to date) has also identified some key issues that
need to be tackled in order for research (in palliative and
supportive care) to progress, and these seem pertinent to
cancer nursing research, too: (a) organizational issues (mini-
mize fragmentation across multiple sites and increase collabo-
rative work); (b) workforce issues (building capacity,
postdoctoral training, combined academic and clinical posts);
(c) infrastructure support (access to dedicated statisticians and
administrative support; data management issues); (d ) increase
in funding; and (e) methodologic issues (tackling problems of
conducting research with seriously ill patients, outcome
measures, involvement of service users).
The interrelationships between the level of academic
maturity of cancer nursing research, cancer nursing practice,
and the dominance of biomedicine requires further analysis.
Reviewing what has been achieved to date can help to
highlight how successful cancer nursing has been in putting
down roots into the research world. It also shows how far we
have still to travel to achieve the goal of being a practice
profession based on research evidence.
Evaluation of any research output in studies such as this
one is neither straightforward nor flawless. We need to
celebrate and be proud of our achievements, as a specialty,
during the past 3 decades, but also it is important to remain
aware of our weaknesses, adopt strategies to further improve
our quality research output in the next decade, and find a
clearer research direction which remains relevant to the
complex reality of cancer nursing practice. There is a need
for more research that is translational in nature (ie, work that
explores the implementation of research evidence in practice).
Other markers of maturity for the cancer nursing research
include more multinational collaborative studies that test the
benefits of specific nursing innovations in practice contexts.
Additionally, it is essential to consider the needs of cancer
patients in developing countries using the combined expertise
that exists within the international academic cancer nursing
community.
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